IMPACT OF APOLIPOPROTEIN E GENE POLYMORPHISM AND PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ON LIPID PROFILE IN PATIENTS ON HEMODIALYSIS

WCN23-0529
Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
 
 
Haemodialysis, Haemodiafiltration and Vascular Access
 
 
IMPACT OF APOLIPOPROTEIN E GENE POLYMORPHISM AND PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ON LIPID PROFILE IN PATIENTS ON HEMODIALYSIS
Arita, K.(1)*;Maeda, K.(2);Oda, H.(2);Masaki, T.(3);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Oda Medical Clinic, Department Of Dialysis, Hiroshima, Japan;(2)Oda Medical Clinic, Department Of Medicine, Hiroshima, Japan;(3)Hiroshima University Hospital, Department Of Nephrology, Hiroshima, Japan;
https://storage.unitedwebnetwork.com/files/1041/8b7e271d6525f0d0d428df9f4bb57672.pdf
 
if any